Melanoma and EGFR lung cancer HLA-I proteogenomics
downstream-application
Melanoma and EGFR lung cancer HLA-I proteogenomics: downstream-application. Proteogenomic HLA class I immunopeptidomics in melanoma and EGFR-mutant lung adenocarcinoma, using de novo search to find variant, PTM and lncRNA-encoded peptides.
Proteogenomic HLA class I immunopeptidomics in melanoma and EGFR-mutant lung adenocarcinoma, using de novo search to find variant, PTM and lncRNA-encoded peptides.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Immunopeptidomics / neoantigen |
Paper describing it
- Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma (2021, Molecular & Cellular Proteomics, peer-reviewed)